This Pharma Magazine is the source for a plethora of unique Pharma articles. Several notable figures from top pharma organisations are featured in the R&D, Manufacturing and Clinical Trials sections, with their expert knowledge of the field.
An estimated million people use connected wearable devices according to IMARC
A marriage between blockchain and the pharma supply chain is not preordained
As per ICH QA guidelines impurity in a drug substance is any component of the drug substance that is not the chemical entity defined as the drug substance and as per ICH QB guidelines impurity in any component of the drug product that is not the chemical entity defined as the drug substance or an excipient in the drug product
Personalised medicine is going to change the shape of the pharmaceutical market in the years to come
The number of new US FDA approved drugs is declining in spite of lots advances made in science
Biologics are drugs isolated from natural sources and include proteins nucleic acids viruses and cells
Pharmaceutical development is in crisis According to the Tufts Center for the Study of Drug Development it now costs US billion to bring a drug to market which is a per cent increase in years
Preclinical trials are the windows of clinical phases in drug discovery and developmental practice
In the early st century one of if not the primary goal of a pharmaceutical facility was to maintain large production lines and attain exceptional productivity and product throughput
By the Global Topical Drug Delivery market is expected to exceed more than US Billion
In any large life science company strategic marketing planning is a carefully organised timetabled and structured process
As the healthcare industry faces increased complexity and stricter requirements for drug development market leaders are looking for new and innovative ways to address these concerns
In this highly competitive market quality has become the market differentiator for almost all products and services
